About: Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.94 (+1.17%)
CTORNASDAQCitius Oncology, Inc.
Citius Oncology, Inc. share price
CTOR price activity
Last Price
$0.940
Change (24hr)
0.01 USD (1.17%)
Volume
56.35K
Volume (4w avg)
-
Open
$0.91
Day Range
$0.86 - $0.96
Previous Close
$0.93
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
CTOR price performance
Delayed
09 Sep, 8:00 pm GMT+0
CTOR Market Signals